Quick Glance: Novartis' Sandoz spin-off's market debut valued in billions
- A sign identifies Novartis' Cambridge facility
- Sandoz (SDZ.S) opened at 24 Swiss francs ($26.05) on Wednesday, valuing the generic and biosimilar drugmaker at 10.3 billion francs on its first day of trading.
#NewsInNumbers – a compilation of interesting numbers that matter!
Read the Mint Newsletter here: https://www.livemint.com/mint-top-newsletter/minttopofthemorning30062022.html
Subscribe: https://livemint.com/newsletters
Calling all St Helens Star readers!
Continuing with our Best of 2022 competition, we need you to tell us who is the best fitness instructor in St Helens ... Show more
sthelensstar.co.uk/news/20147469.st-helens-star-fitness-instructor-year-nominations-open/
🥳 We have a winner! 🥳
Well done to Samantha Envy Houghton and all of our deserving finalists.
Thanks to our Facebook, Instagram, Twitter ... Show more
NOW: #TheYearAhead kicks off with Nykaa’s Falguni Nayar, Novartis’ Vas Narasimhan, Africa Centres for Disease Control and Prevention’s John Nkengasong ...